New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023

Decera Clinical Education Oncology Podcast · Aug 17, 2023 · 14m

In this episode, Catherine C. Coombs, MD, and Toby Eyre, MBChB, MD, discuss key trials presented at ICML 2023 evaluating the use of BTK inhibitors in mantle cell lymphoma (MCL). The discussion includes analyses of:

Phase II trial of acalabrutinib with rituximab for older patients with untreated MCL

BRUIN: updated results of pirtobrutinib in covalent BTK inhibitor–pretreated MCL

IMCL-2015 GELTAMO: 5-year update ibrutinib for untreated indolent MCL

Presenters:

Catherine C. Coombs, MD, MS

Associate Clinical Professor

Division of Hematology/Oncology, Department of Medicine

UCI Health

Orange…